MyFinsight
Home
Blog
About
ROCKWELL MEDICAL, INC. (RMTI)
ROCKWELL MEDICAL, INC. (RMTI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$910K
Free Cash flow
$1,463K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales of investmen...
Accrued and other liabilities
Accounts receivable
Others
Negative Cash Flow Breakdown
Purchases of investments availab...
Purchases of equipment
Deferred consideration paid in c...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,172
-1,605
-554
-4,760
Depreciation and amortization
492
511
546
544
Stock-based compensation
403
479
457
532
Write-off of inventory
0
0
0
0
Change in inventory reserves
-
-
-364
-61
Non-cash lease expense from right of use assets
470
512
525
525
Amortization of debt financing costs and accretion of debt discount and premium
90
88
89
89
Loss on disposal of assets
32
-178
-1
1
Realized gain on sale of investments
130
120
86
181
Gain on early termination of lease liability
-
-
0
24
Accounts receivable
-970
682
61
244
Inventory
-238
-369
-904
-257
Prepaid and other assets
-732
-426
78
573
Accounts payable
-266
1,446
474
23
Lease liabilities
-364
-306
-433
-421
Accrued and other liabilities
1,099
-1,463
625
-139
Deferred license revenue
0
0
0
0
Changes in operating assets and liabilities
-
-
1,613
-
Change in accounts receivable reserve for chargebacks
-450
-
246
-
Net cash provided by (used in) operating activities
2,080
-167
2,291
-1,307
Purchases of investments available-for-sale
7,070
7,072
11,245
7,080
Proceeds from sales of investments available-for-sale
7,200
7,200
7,200
3,000
Purchases of equipment
617
425
86
229
Proceeds from sale of equipment
0
175
-
-
Net cash used in investing activities
-487
-122
-4,131
-4,309
Payments on insurance financing note payable
66
198
198
198
Payments on finance lease liabilities
117
115
111
124
Proceeds from issuance of common stock
-
-
0
7,816
Deferred consideration paid in connection with evoqua asset acquisition
500
500
750
750
Net cash used in financing activities
-683
-813
-1,059
6,744
Effect of exchange rate changes on cash and cash equivalents
-
-
0
0
Net decrease in cash and cash equivalents
910
-1,102
-2,899
1,128
Cash and cash equivalents at beginning of period
9,609
10,711
13,610
15,662
Cash and cash equivalents at end of period
10,519
9,609
10,711
13,610
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accrued and other
liabilities
$1,099K
(150.76%↑ Y/Y)
Accounts receivable
-$970K
(-368.60%↓ Y/Y)
Prepaid and other assets
-$732K
(29.82%↑ Y/Y)
Depreciation and
amortization
$492K
(-55.35%↓ Y/Y)
Non-cash lease expense
from right of use...
$470K
(-56.92%↓ Y/Y)
Stock-based compensation
$403K
(-51.27%↓ Y/Y)
Inventory
-$238K
(85.29%↑ Y/Y)
Amortization of debt
financing costs and...
$90K
(-48.86%↓ Y/Y)
Net cash provided by
(used in) operating...
$2,080K
(226.60%↑ Y/Y)
Canceled cashflow
$2,414K
Net decrease in cash
and cash...
$910K
(128.62%↑ Y/Y)
Canceled cashflow
$1,170K
Net loss
-$1,172K
Change in accounts
receivable reserve for...
-$450K
Lease liabilities
-$364K
(54.95%↑ Y/Y)
Accounts payable
-$266K
(80.54%↑ Y/Y)
Realized gain on sale of
investments
$130K
Loss on disposal of
assets
$32K
(156.14%↑ Y/Y)
Proceeds from sales of
investments...
$7,200K
(20.00%↑ Y/Y)
Net cash used in
financing activities
-$683K
(52.34%↑ Y/Y)
Net cash used in
investing activities
-$487K
(-368.27%↓ Y/Y)
Canceled cashflow
$7,200K
Deferred consideration
paid in connection...
$500K
(-42.59%↓ Y/Y)
Payments on finance lease
liabilities
$117K
(-60.20%↓ Y/Y)
Payments on insurance
financing note payable
$66K
(-75.37%↓ Y/Y)
Purchases of investments
available-for-sale
$7,070K
(20.30%↑ Y/Y)
Purchases of equipment
$617K
(171.81%↑ Y/Y)
Buy us a coffee